Page last updated: 2024-08-22

zirconium and su 11248

zirconium has been researched along with su 11248 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bongaerts, AH; Brouwers, AH; de Haas, S; de Jong, IJ; de Jong, JR; de Vries, EG; Dierckx, RA; Gietema, JA; Hollema, H; Lub-de Hooge, MN; Nagengast, WB; Oosting, SF; Oude Munnink, TH; Scherer, SJ; Sluiter, WJ; van Es, SC	1

Other Studies

1 other study(ies) available for zirconium and su 11248

Article	Year
89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1 Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Carcinoma, Renal Cell; Female; Humans; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radioactive Tracers; Radioisotopes; Radionuclide Imaging; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium	2015

Article

Year

89Zr-bevacizumab PET visualizes heterogeneous tracer accumulation in tumor lesions of renal cell carcinoma patients and differential effects of antiangiogenic treatment.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:1

Topics: Aged; Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Bevacizumab; Biological Transport; Carcinoma, Renal Cell; Female; Humans; Indoles; Interferon-alpha; Kidney Neoplasms; Male; Middle Aged; Pyrroles; Radioactive Tracers; Radioisotopes; Radionuclide Imaging; Sunitinib; Treatment Outcome; Vascular Endothelial Growth Factor A; Zirconium

2015